Market
iRhythm advances cardiac monitoring provision with $287.5m VitalConnect acquisition
iRhythm Technologies acquired VitalConnect for $287.5 million, expanding its cardiac monitoring portfolio. The deal was announced alongside iRhythm's Q2 results, which showed revenue growth of 20.1% year-over-year. VitalConnect's wearable monitoring technology complements iRhythm's existing cardiac diagnostic capabilities.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network